Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 945-065-4 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- secondary literature
- Justification for type of information:
- Data is from secondary source
Data source
Reference
- Reference Type:
- secondary source
- Title:
- Acute dermal toxicity study of test chemical was performed in rabbits.
- Author:
- U.S. Environmental Protection Agency
- Year:
- 2 003
- Bibliographic source:
- Robust Summary & Test Plans
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Principles of method if other than guideline:
- Acute dermal toxicity study of test chemical was performed in rabbits according to OECD Guide-line 402 "Acute Dermal Toxicity".
- GLP compliance:
- not specified
- Test type:
- other: no data available
- Limit test:
- yes
Test material
- Reference substance name:
- 3,9-Bis(2,4-di-tert-butylphenoxy)-2,4,8,10-tetraoxa-3,9 diphosphaspiro[5.5]undecane
- Cas Number:
- 26741-53-7
- Molecular formula:
- C33H50O6P2
- IUPAC Name:
- 3,9-Bis(2,4-di-tert-butylphenoxy)-2,4,8,10-tetraoxa-3,9 diphosphaspiro[5.5]undecane
- Details on test material:
- - Name of test material (IUPAC name): 3,9-bis(2,4-di-tert-butylphenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane
- Common name: Phosphorous acid, cyclic neopentanetetrayl bis(2,4-di-tert-butylphenyl)ester
- Molecular formula: C33H50O6P2
- Molecular weight: 604.7 g/mol
- Smiles notation: O1P(OCC2(COP(OC2)Oc2c(cc(cc2)C(C)(C)C)C(C)(C)C)C1)Oc1c(cc(cc1)C(C)(C)C)C(C)(C)C
-InChl:1S/C33H50O6P2/c1-29(2,3)23-13-15-27(25(17-23)31(7,8)9)38-40-34-19-33(20-35-40)21-36-41(37-22-33)39-28-16-14-24(30(4,5)6)18-26(28)32(10,11)12/h13-18H,19-22H2,1-12H3
- Substance type: Organic
Constituent 1
Test animals
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Details on test animal:
TEST ANIMALS
- Age at study initiation: Approximately 11 weeks old
- Weight at study initiation: 2014 - 2224 g at study initiation
Administration / exposure
- Type of coverage:
- other: dermal
- Vehicle:
- not specified
- Details on dermal exposure:
- No data available
- Duration of exposure:
- No data available
- Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- Total: 10 animals
- Control animals:
- not specified
- Details on study design:
- Details on study design:
- Duration of observation period following administration: 14 days
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight - Statistics:
- No data available
Results and discussion
- Preliminary study:
- No data available
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: No mortality was observed in treated rabbits at 2000 mg/kg bw.
- Mortality:
- No mortality was observed in treated rabbits at 2000 mg/kg bw.
- Clinical signs:
- 5 rabbits had abnormal defecation (soft stool, mucoid feces) on day 0 or 1. One of these animals also had wet, and subsequently, dry brown urogenital matting. These findings were considered to be a result of the bandage/restraint procedures used and not related to the test material. An additional spontaneaous occurrence of soft stool was noted on day 9 for one animal. There were no other findings.
The test material induced generally very slight to slight erythema on all rabbits and very slight to slight edema on 8 rabbits. There was a single occurrence of moderate erythema at the day 1 observation. Desquamation was present on five sites by day 7. There were no other dermal findings. One site had very slight erythema at study termination (day 14). - Body weight:
- There were no remarkable changes or differences noted in body weights during the study.
- Gross pathology:
- In necropsy findings, accessory splenic tissue, a common congenital abnormality in this strain of rabbit, was noted for four animals at the terminal necropsy.
There were no other gross necropsy findings for all examined tissues. - Other findings:
- No data available
Applicant's summary and conclusion
- Interpretation of results:
- other: not classified
- Conclusions:
- The LD50 value was considered to be >2000 mg/kg bw,when 10 male and female New Zealand white rabbits were treated with test chemical according to OECD Guide-line 402 "Acute Dermal Toxicity" by dermal application.
- Executive summary:
In acute dermal toxicity study,10 male and female New Zealand white rabbits were treated with test chemical in the concentration of 2000 mg/kg bw according to OECD Guide-line 402 "Acute Dermal Toxicity"by dermal application for 14 days of observation period.No mortality was observed in treated rabbits at dose 2000 mg/kg bw.5 rabbits had abnormal defecation (soft stool, mucoid feces) on day 0 or 1. One of these animals also had wet, and subsequently, dry brown urogenital matting. These findings were considered to be a result of the bandage/restraint procedures used and not related to the test material. An additional spontaneaous occurrence of soft stool was noted on day 9 for one animal. There were no other findings. The test material induced generally very slight to slight erythema on all rabbits and very slight to slight edema on 8 rabbits. There was a single occurrence of moderate erythema at the day 1 observation. Desquamation was present on five sites by day 7. There were no other dermal findings. One site had very slight erythema at study termination (day 14). There were no remarkable changes or differences noted in body weights during the study. In necropsy findings, accessory splenic tissue, a common congenital abnormality in this strain of rabbit, was noted for four animals at the terminal necropsy. There were no other gross necropsy findings for all examined tissues.Therefore, LD50 value was considered to be >2000 mg/kg bw,when rabbits were treated with test chemical by dermal application.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.